Note: Vera Therapeutics's revenues are gauged from an analysis of company filings.
Vera Therapeutics's Income Statement (based on Industry Averages)
Vera Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Vera Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
February 25, 2021
23
100%
$71 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Vera Therapeutics is developing and marketing.
Vera Therapeutics doesn't have any recent trademark applications, indicating Vera Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
VERA THERAPEUTICS Pharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases
02/13/2020
TRUCODE Gene therapy products, namely, synthetic molecules for the treatment of genetic diseases; pharmaceutical preparations for prevention and treatment of genetic conditions in humans and animals
04/03/2017
LITEBRIGHT Chemical reagents, commonly known as probes, for scientific or research use that enable the detection of DNA, RNA or protein in solution, cell and tissue samples with fluorescence detection
05/21/2013
See all trademarks and details in the Full Report.
Market Share of Vera Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Vera Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Vera Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Vera Therapeutics's Fastest Growing Competitors
These companies are in the same general field as Vera Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.